News Website

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers TradingView

Published: May 7, 2026, 12:05 p.m.

Read Full Article

Obesity and cancer: How bariatric surgery reduces the risk of 12 cancers - MSN

Obesity and cancer: How bariatric surgery reduces the risk of 12 cancers MSN

Published: May 2, 2026, 4:42 a.m.

Read Full Article

Young Adults in England Face Rising Bowel, Ovarian Cancers - Mirage News

Young Adults in England Face Rising Bowel, Ovarian Cancers Mirage News

Published: April 29, 2026, 8:20 a.m.

Read Full Article

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review - CancerNetwork

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review CancerNetwork

Published: April 27, 2026, 10:49 a.m.

Read Full Article

Mo-Rez shows strong early responses in ovarian, endometrial cancers - Rare Cancer News

Mo-Rez shows strong early responses in ovarian, endometrial cancers Rare Cancer News

Published: April 22, 2026, 4:40 p.m.

Read Full Article

Mo-Rez shows strong early responses in gynecologic cancers - Rare Cancer News

Mo-Rez shows strong early responses in gynecologic cancers Rare Cancer News

Published: April 22, 2026, 2:43 p.m.

Read Full Article

S’pore-led studies make breakthroughs in treating cancers in women - The Straits Times

S’pore-led studies make breakthroughs in treating cancers in women The Straits Times

Published: April 21, 2026, 1:22 p.m.

Read Full Article

S’pore-led studies make breakthroughs in treating challenging cancers in women - The Straits Times

S’pore-led studies make breakthroughs in treating challenging cancers in women The Straits Times

Published: April 21, 2026, 1:20 p.m.

Read Full Article

Empowering women's health with miRNA-integrated nanochemical approaches: from reproductive health to cancer care.

MicroRNAs (miRNAs), a category of small (18-25 nucleotides) non-coding transcripts that modulate gene expression at the post-transcriptional level, are necessary for regulatory processes in female reproduction, specifically in ovarian function …

Published: April 21, 2026, midnight

Read Full Article

GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers - BioXconomy

GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers BioXconomy

Published: April 20, 2026, 2:38 p.m.

Read Full Article

Latest Articles

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

Obesity and cancer: How bariatric surgery reduces the risk of 12 cancers - MSN

Young Adults in England Face Rising Bowel, Ovarian Cancers - Mirage News

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review - CancerNetwork

Mo-Rez shows strong early responses in ovarian, endometrial cancers - Rare Cancer News

Mo-Rez shows strong early responses in gynecologic cancers - Rare Cancer News

S’pore-led studies make breakthroughs in treating cancers in women - The Straits Times

S’pore-led studies make breakthroughs in treating challenging cancers in women - The Straits Times

Empowering women's health with miRNA-integrated nanochemical approaches: from reproductive health to cancer care.

GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers - BioXconomy

Subscribe to Our Newsletter